首页> 外国专利> USE OF AN ANTIBODY THAT BLOCKS AN INHIBITORY RECEPTOR OR STIMULATES AN ACTIVATING RECEPTOR OF AN NK CELL FOR THE PREPARATION OF MEDICAMENTS, FOR USE IN COMBINATION WITH A THERAPEUTIC ANTIBODY, IN THE TREATMENT OF A DISEASE, PHARMACEUTICAL COMPOSITIONS COMPRISING SAID ANTIBODIES AND METHODS TO IDENTIFY SAID ANTIBODIES

USE OF AN ANTIBODY THAT BLOCKS AN INHIBITORY RECEPTOR OR STIMULATES AN ACTIVATING RECEPTOR OF AN NK CELL FOR THE PREPARATION OF MEDICAMENTS, FOR USE IN COMBINATION WITH A THERAPEUTIC ANTIBODY, IN THE TREATMENT OF A DISEASE, PHARMACEUTICAL COMPOSITIONS COMPRISING SAID ANTIBODIES AND METHODS TO IDENTIFY SAID ANTIBODIES

机译:阻断神经抑制因子受体或刺激NK细胞的活化受体的抗体在制备药物中的用途,与治疗性抗体结合使用,以治疗疾病,药物成分和病原体组成抗体

摘要

The present invention relates, generally, to methods and compositions for increasing the efficiency of therapeutic antibodies. Their efficiency is enhanced through the increase of the ADCC mechanism. More particularly, the invention relates to the use of a therapeutic antibody in combination with compounds that block an inhibitory receptor or stimulate an activating receptor of an NK cell in order to enhance the efficiency of the treatment with therapeutic antibodies in human subjects.
机译:本发明通常涉及用于提高治疗性抗体的效率的方法和组合物。通过增加ADCC机制可以提高其效率。更具体地,本发明涉及治疗性抗体与阻断NK细胞的抑制性受体或刺激NK细胞的激活性受体的化合物联合使用以增强用治疗性抗体在人类受试者中治疗的效率的用途。

著录项

  • 公开/公告号IL172679A

    专利类型

  • 公开/公告日2011-04-28

    原文格式PDF

  • 申请/专利权人 INNATE PHARMA;UNIVERSITA DEGLI STUDI DI PERUGIA;

    申请/专利号IL20050172679

  • 发明设计人

    申请日2005-12-19

  • 分类号C07K16/28;C12N5/0783;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号